Gastrointestinal Stromal Tumors, Somatic Mutations and Candidate Genetic Risk Variants

被引:24
作者
O'Brien, Katie M. [1 ]
Orlow, Irene [2 ]
Antonescu, Cristina R. [3 ]
Ballman, Karla [4 ]
McCall, Linda [5 ]
DeMatteo, Ronald [6 ]
Engel, Lawrence S. [1 ]
机构
[1] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[4] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
[5] Amer Coll Surg, Oncol Grp, Durham, NC USA
[6] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
来源
PLOS ONE | 2013年 / 8卷 / 04期
关键词
S-TRANSFERASE M1; CYP1B1 LEU432VAL POLYMORPHISM; COLORECTAL-CANCER RISK; SOFT-TISSUE SARCOMA; SINGLE NUCLEOTIDE POLYMORPHISMS; GERMLINE MUTATION; BLADDER-CANCER; DNA-REPAIR; C-KIT; ASSOCIATION;
D O I
10.1371/journal.pone.0062119
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Gastrointestinal stromal tumors (GISTs) are rare but treatable soft tissue sarcomas. Nearly all GISTs have somatic mutations in either the KIT or PDGFRA gene, but there are no known inherited genetic risk factors. We assessed the relationship between KIT/PDGFRA mutations and select deletions or single nucleotide polymorphisms (SNPs) in 279 participants from a clinical trial of adjuvant imatinib mesylate. Given previous evidence that certain susceptibility loci and carcinogens are associated with characteristic mutations, or "signatures'' in other cancers, we hypothesized that the characteristic somatic mutations in the KIT and PDGFRA genes in GIST tumors may similarly be mutational signatures that are causally linked to specific mutagens or susceptibility loci. As previous epidemiologic studies suggest environmental risk factors such as dioxin and radiation exposure may be linked to sarcomas, we chose 208 variants in 39 candidate genes related to DNA repair and dioxin metabolism or response. We calculated adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the association between each variant and 7 categories of tumor mutation using logistic regression. We also evaluated gene-level effects using the sequence kernel association test (SKAT). Although none of the association p-values were statistically significant after adjustment for multiple comparisons, SNPs in CYP1B1 were strongly associated with KIT exon 11 codon 557-8 deletions (OR = 1.9, 95% CI: 1.3-2.9 for rs2855658 and OR = 1.8, 95% CI: 1.2-2.7 for rs1056836) and wild type GISTs (OR = 2.7, 95% CI: 1.5-4.8 for rs1800440 and OR = 0.5, 95% CI: 0.3-0.9 for rs1056836). CYP1B1 was also associated with these mutations categories in the SKAT analysis (p = 0.002 and p = 0.003, respectively). Other potential risk variants included GSTM1, RAD23B and ERCC2. This preliminary analysis of inherited genetic risk factors for GIST offers some clues about the disease's genetic origins and provides a starting point for future candidate gene or gene-environment research.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Metastatic gastrointestinal stromal tumors
    Aubin, Francine
    Blanke, Charles D.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 : 9 - 14
  • [42] Cytomorphology of gastrointestinal stromal tumors and extra-gastrointestinal stromal tumors: A comprehensive morphologic study
    Vij, M.
    Agrawal, V
    Kumar, A.
    Pandey, R.
    JOURNAL OF CYTOLOGY, 2013, 30 (01) : 8 - 12
  • [43] Identification of New Tumor-Related Gene Mutations in Chinese Gastrointestinal Stromal Tumors
    Feng, Yuyang
    Yao, Surui
    Pu, Zhening
    Cheng, Han
    Fei, Bojian
    Zou, Jian
    Huang, Zhaohui
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [44] KIT and BRAF heterogeneous mutations in gastrointestinal stromal tumors after secondary imatinib resistance
    Zheng, Song
    Huang, Ke-er
    Pan, Yue-long
    Zhou, Yao
    Pan, Song-dan
    Li, Xin
    Jia, Jing
    Zheng, Xiao-liang
    Tao, De-you
    GASTRIC CANCER, 2015, 18 (04) : 796 - 802
  • [45] Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors
    Rossi, Sabrina
    Sbaraglia, Marta
    Dell'Orto, Marta Campo
    Gasparotto, Daniela
    Cacciatore, Matilde
    Boscato, Elena
    Carraro, Valentina
    Toffolatti, Luisa
    Gallina, Giovanna
    Niero, Monia
    Pilozzi, Emanuela
    Mandolesi, Alessandra
    Sessa, Fausto
    Sonzogni, Aurelio
    Mancini, Cristina
    Mazzoleni, Guido
    Romeo, Salvatore
    Maestro, Roberta
    Dei Tos, Angelo P.
    ONCOTARGET, 2016, 7 (21) : 30109 - 30118
  • [46] A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del)
    Huss, Sebastian
    Kuenstlinger, Helen
    Wardelmann, Eva
    Kleine, Michaela A.
    Binot, Elke
    Merkelbach-Bruse, Sabine
    Ruediger, Thomas
    Mittler, Jens
    Hartmann, Wolfgang
    Buettner, Reinhard
    Schildhaus, Hans-Ulrich
    MODERN PATHOLOGY, 2013, 26 (07) : 1004 - 1012
  • [47] Gastrointestinal stromal tumors: report of an audit and review of the literature
    Biasco, Guido
    Velo, Daniela
    Angriman, Imerio
    Astorino, Maria
    Baldan, Anna
    Baseggio, Matteo
    Basso, Umberto
    Battaglia, Giorgio
    Bertin, Matteo
    Bertorelle, Roberta
    Bocus, Paolo
    Brosolo, Piero
    Bulzacchi, Andrea
    Cannizzaro, Renato
    Da Dalt, Gian Franco
    Di Battista, Monica
    Errante, Domenico
    Fedrigo, Marny
    Frustaci, Sergio
    Lionetti, Ivana
    Massani, Marco
    Mencarelli, Roberto
    Montesco, Maria Cristina
    Norberto, Lorenzo
    Pantaleo, Maria Abbondanza
    Pasquali, Claudio
    Pastorelli, Davide
    Rossi, Carlo Remigio
    Ruffolo, Cesare
    Salvagno, Luigi
    Saponara, Maria Stella
    Vittadello, Fabrizio
    Zaccaria, Francesco
    Zovato, Stefania
    Farinati, Fabio
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2009, 18 (02) : 106 - 116
  • [48] Interaction analysis between germline genetic variants and somatic mutations in head and neck cancer
    Feng, Guanying
    Feng, Hongjie
    Qi, Yibo
    Wang, Tianxiao
    Ni, Nan
    Wu, Jia
    Yuan, Hua
    ORAL ONCOLOGY, 2022, 128
  • [49] Gastrointestinal stromal tumors of the stomach and duodenum
    Cassier, Philippe A.
    Blay, Jean Yves
    CURRENT OPINION IN GASTROENTEROLOGY, 2011, 27 (06) : 571 - 575
  • [50] Gastrointestinal Stromal Tumors: Current Management
    Pisters, Peter W. T.
    Patel, Shreyaskumar R.
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (05) : 530 - 538